Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma
暂无分享,去创建一个
J. Bosch-Barrera | J. Sánchez | T. Morán | A. Insa | X. Mielgo | M. Majem | L. Cabezón-Gutiérrez | S. Ponce | R. Blanco | Ainhoa Hernández | M. Riudavets | M. Alonso | P. Diz Taín | E. Gálvez | D. Roa